Loading company…

Amgen Inc.

AMGNCIK 000031815419 fiscal years, 71 SEC filings

RevenueFY2025

$36.75B10.0%

Net incomeFY2025

$7.71B88.5%

Free cash flowFY2025

$8.10B22.1%

Diluted EPSFY2025

$14.2388.2%

Trends

FY2007–FY2025 · hover a year for its filing

Revenue & net incomeRevenueNet income

revenue 2.5× since FY2007 · net margin 20.8% → 21.0%

MarginsNet marginFCF margin

FY2025: net 21.0% · free cash flow 22.0% of revenue

Cash flowOperating cash flowFree cash flow

FY2025: $9.96B operating cash − $1.86B capex = $8.10B free cash flow

Returns on capitalReturn on equityReturn on assets

return on equity 19% (FY2008) → 89% (FY2025) · on assets 8.5%

USD millions, except per-share values; share counts in millions. Click a value to open its filing; hover for the XBRL tag.

USD millions	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016	FY2015	FY2014
Revenue	36,751	33,424	28,190	26,323	25,979	25,424	23,362	23,747	22,849	22,991	21,662	20,063
Net income	7,711	4,090	6,717	6,552	5,893	7,264	7,842	8,394	1,979	7,722	6,939	5,158
Diluted EPS	14.23	7.56	12.49	12.11	10.28	12.31	12.88	12.62	2.69	10.24	9.06	6.70
Diluted shares	542	541	538	541	573	590	609	665	735	754	766	770
Operating cash flow	9,958	11,490	8,471	9,721	9,261	10,497	9,150	11,296	11,177	10,354	9,731	8,952
Capital expenditures	1,858	1,096	1,112	936	880	608	618	738	664	738	594	718
Free cash flow	8,100	10,394	7,359	8,785	8,381	9,889	8,532	10,558	10,513	9,616	9,137	8,234
Cash & equivalents	9,129	11,973	10,944	7,629	7,989	6,266	6,037	6,945	3,800	3,241	4,144	3,731
Total assets	90,586	91,839	97,154	65,121	61,165	62,948	59,707	66,416	79,954	77,626	71,449	69,009
Shareholders' equity	8,658	5,877	6,232	3,661	6,700	9,409	9,673	12,500	25,241	29,875	28,083	25,778

As reported in SEC filings; a missing tag shows “—”, never zero. Free cash flow is operating cash flow − capex. Methodology